Josh Golomb
Partner·OrbiMed
Josh Golomb is a Partner on OrbiMed's Public Equity team focusing on biotechnology, and he joined the firm in 2021. He has more than 20 years of investment experience in biotechnology and pharmaceuticals. Before OrbiMed, he was a Senior Analyst covering biotech and pharmaceuticals at HealthCor Management and held buyside analyst roles at Millennium, Citadel, Diamondback and ProMed.
See the rest of Josh Golomb's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.